Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Hillman Reports Fourth Quarter and Record Full Year 2025 Results; Provides 2026 Guidance
-
Watsco Boosts Annual Dividend 10% to $13.20 Per Share
-
Tradewinds Universal Secures $10 Million Equity Line to Accelerate Roll-Up of High-Revenue Assets
-
ASP Isotopes Announces Quantum Leap Energy to Establish Global Headquarters in Austin, TX
-
Nature Medicine Publishes Helus Pharma’s Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder
-
ZenaTech Advances its Autonomous AI Drone Power Wash Platform and Dubai Drone as a Service Presence
-
BridgeBio to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 24, 2026 at 4:30 pm ET
-
Habit Introduces a Fresh New Menu Lineup
-
GT Biopharma to Present at the Centurion One Capital 9th Annual Toronto Growth Conference
-
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
-
Applied Materials to Participate in Upcoming Investor Conferences
-
Survey Reveals Lender Concern with Fraud, Defaults and AI
-
Sotera Health Announces Fourth-Quarter and Full-Year 2025 Earnings Release Date
-
Brixton Metals Corporation Announces Share Consolidation
-
Cronos Launches New All-in-One Vape, Spinach PUFFERZ™
-
Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd
-
Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update
-
Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser
-
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin
-
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin
-
Prof. Lalith Kumar Shiyam Sundar, LMU Hospital Munich, received the ICPO Research Grant for “AI-driven Advancements in Precision Oncology”
-
SAIC Announces CEO Appointment
-
CorVel Earns Sixth Consecutive Great Place To Work® Certification™, Reflecting Continued Investment in Employees and Innovation
-
DBGI Announces Extension of Warrant Exercise Period
-
FLSmidth announces intention to initiate a new share buy-back programme of up to DKK 1.0 billion
-
Lifecore Biomedical to Participate at DCAT Week 2026
-
Kraig Biocraft Laboratories Activates First Wave of 2026 Production Program
-
Crane NXT Announces Live Webcast of 2026 Investor Day
-
OroraTech Appoints Distributed Satellite Pioneer Ignacio Zuleta as CTPO to Lead the Next Era of Global Thermal Intelligence
-
Applitools Strengthens Leadership Team to Drive Next Phase of Growth
-
Gilat Receives $9 Million Order for Defense SATCOM Solutions from Israel’s Ministry of Defense
-
DCIP Geophysical Survey Underway on VR’s Bonita Porphyry Copper-Gold Project in Nevada
-
Wallbridge Launches 2026 Exploration and Technical Studies Programs
-
Ocular Therapeutix™ Reports Positive Results from Landmark SOL-1 Phase 3 Superiority Trial in Wet AMD
-
NexLiving Communities Announces Property Disposition and Declares Quarterly Dividend
-
Westhaven Launches 50,000m 2026 Drill Program at the Shovelnose Gold and Silver Project, Southern British Columbia
-
Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack™ Kits
-
BioCryst to Present at Upcoming Investor Conference
-
Bridging Continents and Capital: How ADIS26 Connects Africa’s Innovators with Silicon Valley
-
Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
-
Yorkshire Publishing Earns BBB® Accreditation
-
Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
-
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
eToro Reports Fourth Quarter and Full Year 2025 Results
-
Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
-
Can-Fite Announces Scientific Breakthrough Publication Demonstrating Anti-Obesity Effect of Namodenoson
-
AtaiBeckley To Participate in Upcoming Investor Conferences
-
Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
-
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

